Fycompa 0.5 mg / mL, Suspension zum Einnehmen

7680676650018 CH-67665 suspension
Fycompa 0.5 mg / mL, Suspension zum Einnehmen
Fycompa 0.5 mg / mL, Suspension zum Einnehmen
Fycompa 0.5 mg / mL, Suspension zum Einnehmen
1 / 3
google

Article details

Package size
340
Selling units
340
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
perampanelum
0.5 MG Substance Wirkstoff (Principe actif)
sorbitolum liquidum cristallisabile
- Substance HNIDK
sorbitolum
175.0 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
dimeticonum
- Substance HNIDK
polysorbatum 65
- Substance HNIDK
methylcellulosum
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
macrogoli stearas
- Substance HNIDK
E 210
- Substance HBESI
E 200
- Substance HNIDK
acidum sulfuricum
- Substance HNIDK
acidum citricum
- Substance HNIDK
E 211
1.1 MG Substance HBESI
aqua purificata
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
67665
Drug name
Fycompa, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AX22
Authorization status
Z
Dispensing category
B
First authorization
16/04/2020
Authorization expiration date
31/12/9999
IT Number
01.07.1.
Domain
Human medicine
Field of application
Antiepileptikum

Package details

Description (FR)
FYCOMPA susp 0.5 mg/ml buvable fl 340 ml
Description (DE)
FYCOMPA Susp 0.5 mg/ml zum Einnehmen Fl 340 ml
Market launch
16/04/2020
Narcotic (BTM)
No
Buy us a coffee Explore the data